Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02681549
Brief Title: Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer

First Submitted : February 9, 2016
First Submitted that Met QC Criteria : February 11, 2016
First Posted : February 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 10, 2019
Last Update Posted : July 11, 2019